elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33830941-E060C125-D648-469D-8E03-3749331A9FBC
Q33830941-E060C125-D648-469D-8E03-3749331A9FBC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33830941-E060C125-D648-469D-8E03-3749331A9FBC
Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study
P2860
Q33830941-E060C125-D648-469D-8E03-3749331A9FBC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33830941-E060C125-D648-469D-8E03-3749331A9FBC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51202cce834de7db9524de7937d97e73bc76f05d
P2860
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.